Title : A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy.

Pub. Date : 2020 Mar 21

PMID : 32245188






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The chemotherapeutics sorafenib and regorafenib inhibit shedding of MHC class I-related chain A (MICA) from hepatocellular carcinoma (HCC) cells by suppressing a disintegrin and metalloprotease 9 (ADAM9). Sorafenib MHC class I polypeptide-related sequence A Homo sapiens
2 The chemotherapeutics sorafenib and regorafenib inhibit shedding of MHC class I-related chain A (MICA) from hepatocellular carcinoma (HCC) cells by suppressing a disintegrin and metalloprotease 9 (ADAM9). Sorafenib MHC class I polypeptide-related sequence A Homo sapiens